世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 脳神経外科用薬剤-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Neurosurgery Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 脳神経外科用薬剤の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドル規模に再調整され、予測期間2025-2031年のCAGRは%になると予測されている。 脳神経外科は神経系の手術である... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー脳神経外科用薬剤の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドル規模に再調整され、予測期間2025-2031年のCAGRは%になると予測されている。脳神経外科は神経系の手術である。ほとんどの場合、脳神経外科は脳の手術に過ぎないと考えられているが、深く考えてみるとそれ以上のものである。脳神経外科は、脳に関する怪我や病気の診断に関わる医学の専門分野である。患者や怪我、病気によっては、医師が手術以外の方法を選択することもある。市場には、神経外科手術後の発作や痛みを和らげる薬がいくつかあります。ただし、医師の承認が必要である。 当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5%で成長する見込みである。世界の医療支出は世界GDPの10％を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっている。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。この市場を牽引しているのは、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断・治療に対する意識の高まりなど、いくつかの要因である。 本レポートは、脳神経外科用薬剤の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当て、包括的に紹介することを目的としています。 脳神経外科用薬剤の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データおよび予測データとともに、販売数量（K単位）および販売収益（百万ドル）で提供されます。量的および質的分析により、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、脳神経外科用薬剤に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 ファイザー アストラゼネカ バイオジェン ジョンソン＆ジョンソン ABBVIE 武田薬品工業 UCB イプセン スタンディグム ブルースター・ジェノミック トニックス・ファーマシューティカルズ ブラックソーン・セラピューティクス クエントリックス レン・ファーマシューティカルズ タイプ別セグメント 錠剤 溶液 カプセル その他 用途別セグメント 病院 クリニック その他 地域別 北米 アメリカ カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートのスコープ、世界の総市場規模（金額、数量、価格）を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：脳神経外科用薬剤メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第5章：脳神経外科治療薬の地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。 第6章：国別脳神経外科治療薬の売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Neurosurgery Drug Product Introduction 1.2 Global Neurosurgery Drug Market Size Forecast 1.2.1 Global Neurosurgery Drug Sales Value (2020-2031) 1.2.2 Global Neurosurgery Drug Sales Volume (2020-2031) 1.2.3 Global Neurosurgery Drug Sales Price (2020-2031) 1.3 Neurosurgery Drug Market Trends & Drivers 1.3.1 Neurosurgery Drug Industry Trends 1.3.2 Neurosurgery Drug Market Drivers & Opportunity 1.3.3 Neurosurgery Drug Market Challenges 1.3.4 Neurosurgery Drug Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Neurosurgery Drug Players Revenue Ranking (2024) 2.2 Global Neurosurgery Drug Revenue by Company (2020-2025) 2.3 Global Neurosurgery Drug Players Sales Volume Ranking (2024) 2.4 Global Neurosurgery Drug Sales Volume by Company Players (2020-2025) 2.5 Global Neurosurgery Drug Average Price by Company (2020-2025) 2.6 Key Manufacturers Neurosurgery Drug Manufacturing Base and Headquarters 2.7 Key Manufacturers Neurosurgery Drug Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Neurosurgery Drug 2.9 Neurosurgery Drug Market Competitive Analysis 2.9.1 Neurosurgery Drug Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Neurosurgery Drug Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Tablets 3.1.2 Solution 3.1.3 Capsules 3.1.4 Others 3.2 Global Neurosurgery Drug Sales Value by Type 3.2.1 Global Neurosurgery Drug Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Neurosurgery Drug Sales Value, by Type (2020-2031) 3.2.3 Global Neurosurgery Drug Sales Value, by Type (%) (2020-2031) 3.3 Global Neurosurgery Drug Sales Volume by Type 3.3.1 Global Neurosurgery Drug Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Neurosurgery Drug Sales Volume, by Type (2020-2031) 3.3.3 Global Neurosurgery Drug Sales Volume, by Type (%) (2020-2031) 3.4 Global Neurosurgery Drug Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Neurosurgery Drug Sales Value by Application 4.2.1 Global Neurosurgery Drug Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Neurosurgery Drug Sales Value, by Application (2020-2031) 4.2.3 Global Neurosurgery Drug Sales Value, by Application (%) (2020-2031) 4.3 Global Neurosurgery Drug Sales Volume by Application 4.3.1 Global Neurosurgery Drug Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Neurosurgery Drug Sales Volume, by Application (2020-2031) 4.3.3 Global Neurosurgery Drug Sales Volume, by Application (%) (2020-2031) 4.4 Global Neurosurgery Drug Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Neurosurgery Drug Sales Value by Region 5.1.1 Global Neurosurgery Drug Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Neurosurgery Drug Sales Value by Region (2020-2025) 5.1.3 Global Neurosurgery Drug Sales Value by Region (2026-2031) 5.1.4 Global Neurosurgery Drug Sales Value by Region (%), (2020-2031) 5.2 Global Neurosurgery Drug Sales Volume by Region 5.2.1 Global Neurosurgery Drug Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Neurosurgery Drug Sales Volume by Region (2020-2025) 5.2.3 Global Neurosurgery Drug Sales Volume by Region (2026-2031) 5.2.4 Global Neurosurgery Drug Sales Volume by Region (%), (2020-2031) 5.3 Global Neurosurgery Drug Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Neurosurgery Drug Sales Value, 2020-2031 5.4.2 North America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Neurosurgery Drug Sales Value, 2020-2031 5.5.2 Europe Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Neurosurgery Drug Sales Value, 2020-2031 5.6.2 Asia Pacific Neurosurgery Drug Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Neurosurgery Drug Sales Value, 2020-2031 5.7.2 South America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Neurosurgery Drug Sales Value, 2020-2031 5.8.2 Middle East & Africa Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Neurosurgery Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Neurosurgery Drug Sales Value 6.2.1 Key Countries/Regions Neurosurgery Drug Sales Value, 2020-2031 6.2.2 Key Countries/Regions Neurosurgery Drug Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Neurosurgery Drug Sales Value, 2020-2031 6.3.2 United States Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Neurosurgery Drug Sales Value, 2020-2031 6.4.2 Europe Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Neurosurgery Drug Sales Value, 2020-2031 6.5.2 China Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.5.3 China Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Neurosurgery Drug Sales Value, 2020-2031 6.6.2 Japan Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Neurosurgery Drug Sales Value, 2020-2031 6.7.2 South Korea Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Neurosurgery Drug Sales Value, 2020-2031 6.8.2 Southeast Asia Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Neurosurgery Drug Sales Value, 2020-2031 6.9.2 India Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.9.3 India Neurosurgery Drug Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Information 7.1.2 Pfizer Introduction and Business Overview 7.1.3 Pfizer Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Pfizer Neurosurgery Drug Product Offerings 7.1.5 Pfizer Recent Development 7.2 AstraZeneca 7.2.1 AstraZeneca Company Information 7.2.2 AstraZeneca Introduction and Business Overview 7.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AstraZeneca Neurosurgery Drug Product Offerings 7.2.5 AstraZeneca Recent Development 7.3 Biogen 7.3.1 Biogen Company Information 7.3.2 Biogen Introduction and Business Overview 7.3.3 Biogen Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Biogen Neurosurgery Drug Product Offerings 7.3.5 Biogen Recent Development 7.4 Jhonson & Jhonson 7.4.1 Jhonson & Jhonson Company Information 7.4.2 Jhonson & Jhonson Introduction and Business Overview 7.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Jhonson & Jhonson Neurosurgery Drug Product Offerings 7.4.5 Jhonson & Jhonson Recent Development 7.5 ABBVIE 7.5.1 ABBVIE Company Information 7.5.2 ABBVIE Introduction and Business Overview 7.5.3 ABBVIE Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 ABBVIE Neurosurgery Drug Product Offerings 7.5.5 ABBVIE Recent Development 7.6 Takeda Pharmaceuticals 7.6.1 Takeda Pharmaceuticals Company Information 7.6.2 Takeda Pharmaceuticals Introduction and Business Overview 7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Offerings 7.6.5 Takeda Pharmaceuticals Recent Development 7.7 UCB 7.7.1 UCB Company Information 7.7.2 UCB Introduction and Business Overview 7.7.3 UCB Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 UCB Neurosurgery Drug Product Offerings 7.7.5 UCB Recent Development 7.8 IPSEN 7.8.1 IPSEN Company Information 7.8.2 IPSEN Introduction and Business Overview 7.8.3 IPSEN Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 IPSEN Neurosurgery Drug Product Offerings 7.8.5 IPSEN Recent Development 7.9 Standigm 7.9.1 Standigm Company Information 7.9.2 Standigm Introduction and Business Overview 7.9.3 Standigm Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Standigm Neurosurgery Drug Product Offerings 7.9.5 Standigm Recent Development 7.10 BlueStar Genomic 7.10.1 BlueStar Genomic Company Information 7.10.2 BlueStar Genomic Introduction and Business Overview 7.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 BlueStar Genomic Neurosurgery Drug Product Offerings 7.10.5 BlueStar Genomic Recent Development 7.11 Tonix Pharmaceuticals 7.11.1 Tonix Pharmaceuticals Company Information 7.11.2 Tonix Pharmaceuticals Introduction and Business Overview 7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Offerings 7.11.5 Tonix Pharmaceuticals Recent Development 7.12 BlackThorn Therapeutics 7.12.1 BlackThorn Therapeutics Company Information 7.12.2 BlackThorn Therapeutics Introduction and Business Overview 7.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Offerings 7.12.5 BlackThorn Therapeutics Recent Development 7.13 Quentrix 7.13.1 Quentrix Company Information 7.13.2 Quentrix Introduction and Business Overview 7.13.3 Quentrix Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Quentrix Neurosurgery Drug Product Offerings 7.13.5 Quentrix Recent Development 7.14 Wren Pharmaceuticals 7.14.1 Wren Pharmaceuticals Company Information 7.14.2 Wren Pharmaceuticals Introduction and Business Overview 7.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Offerings 7.14.5 Wren Pharmaceuticals Recent Development 8 Industry Chain Analysis 8.1 Neurosurgery Drug Industrial Chain 8.2 Neurosurgery Drug Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Neurosurgery Drug Sales Model 8.5.2 Sales Channel 8.5.3 Neurosurgery Drug Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Neurosurgery Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Neurosurgery Drug Product Introduction 1.2 Global Neurosurgery Drug Market Size Forecast 1.2.1 Global Neurosurgery Drug Sales Value (2020-2031) 1.2.2 Global Neurosurgery Drug Sales Volume (2020-2031) 1.2.3 Global Neurosurgery Drug Sales Price (2020-2031) 1.3 Neurosurgery Drug Market Trends & Drivers 1.3.1 Neurosurgery Drug Industry Trends 1.3.2 Neurosurgery Drug Market Drivers & Opportunity 1.3.3 Neurosurgery Drug Market Challenges 1.3.4 Neurosurgery Drug Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Neurosurgery Drug Players Revenue Ranking (2024) 2.2 Global Neurosurgery Drug Revenue by Company (2020-2025) 2.3 Global Neurosurgery Drug Players Sales Volume Ranking (2024) 2.4 Global Neurosurgery Drug Sales Volume by Company Players (2020-2025) 2.5 Global Neurosurgery Drug Average Price by Company (2020-2025) 2.6 Key Manufacturers Neurosurgery Drug Manufacturing Base and Headquarters 2.7 Key Manufacturers Neurosurgery Drug Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Neurosurgery Drug 2.9 Neurosurgery Drug Market Competitive Analysis 2.9.1 Neurosurgery Drug Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Neurosurgery Drug Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Tablets 3.1.2 Solution 3.1.3 Capsules 3.1.4 Others 3.2 Global Neurosurgery Drug Sales Value by Type 3.2.1 Global Neurosurgery Drug Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Neurosurgery Drug Sales Value, by Type (2020-2031) 3.2.3 Global Neurosurgery Drug Sales Value, by Type (%) (2020-2031) 3.3 Global Neurosurgery Drug Sales Volume by Type 3.3.1 Global Neurosurgery Drug Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Neurosurgery Drug Sales Volume, by Type (2020-2031) 3.3.3 Global Neurosurgery Drug Sales Volume, by Type (%) (2020-2031) 3.4 Global Neurosurgery Drug Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Neurosurgery Drug Sales Value by Application 4.2.1 Global Neurosurgery Drug Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Neurosurgery Drug Sales Value, by Application (2020-2031) 4.2.3 Global Neurosurgery Drug Sales Value, by Application (%) (2020-2031) 4.3 Global Neurosurgery Drug Sales Volume by Application 4.3.1 Global Neurosurgery Drug Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Neurosurgery Drug Sales Volume, by Application (2020-2031) 4.3.3 Global Neurosurgery Drug Sales Volume, by Application (%) (2020-2031) 4.4 Global Neurosurgery Drug Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Neurosurgery Drug Sales Value by Region 5.1.1 Global Neurosurgery Drug Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Neurosurgery Drug Sales Value by Region (2020-2025) 5.1.3 Global Neurosurgery Drug Sales Value by Region (2026-2031) 5.1.4 Global Neurosurgery Drug Sales Value by Region (%), (2020-2031) 5.2 Global Neurosurgery Drug Sales Volume by Region 5.2.1 Global Neurosurgery Drug Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Neurosurgery Drug Sales Volume by Region (2020-2025) 5.2.3 Global Neurosurgery Drug Sales Volume by Region (2026-2031) 5.2.4 Global Neurosurgery Drug Sales Volume by Region (%), (2020-2031) 5.3 Global Neurosurgery Drug Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Neurosurgery Drug Sales Value, 2020-2031 5.4.2 North America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Neurosurgery Drug Sales Value, 2020-2031 5.5.2 Europe Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Neurosurgery Drug Sales Value, 2020-2031 5.6.2 Asia Pacific Neurosurgery Drug Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Neurosurgery Drug Sales Value, 2020-2031 5.7.2 South America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Neurosurgery Drug Sales Value, 2020-2031 5.8.2 Middle East & Africa Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Neurosurgery Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Neurosurgery Drug Sales Value 6.2.1 Key Countries/Regions Neurosurgery Drug Sales Value, 2020-2031 6.2.2 Key Countries/Regions Neurosurgery Drug Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Neurosurgery Drug Sales Value, 2020-2031 6.3.2 United States Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Neurosurgery Drug Sales Value, 2020-2031 6.4.2 Europe Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Neurosurgery Drug Sales Value, 2020-2031 6.5.2 China Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.5.3 China Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Neurosurgery Drug Sales Value, 2020-2031 6.6.2 Japan Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Neurosurgery Drug Sales Value, 2020-2031 6.7.2 South Korea Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Neurosurgery Drug Sales Value, 2020-2031 6.8.2 Southeast Asia Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Neurosurgery Drug Sales Value, 2020-2031 6.9.2 India Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.9.3 India Neurosurgery Drug Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Information 7.1.2 Pfizer Introduction and Business Overview 7.1.3 Pfizer Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Pfizer Neurosurgery Drug Product Offerings 7.1.5 Pfizer Recent Development 7.2 AstraZeneca 7.2.1 AstraZeneca Company Information 7.2.2 AstraZeneca Introduction and Business Overview 7.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AstraZeneca Neurosurgery Drug Product Offerings 7.2.5 AstraZeneca Recent Development 7.3 Biogen 7.3.1 Biogen Company Information 7.3.2 Biogen Introduction and Business Overview 7.3.3 Biogen Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Biogen Neurosurgery Drug Product Offerings 7.3.5 Biogen Recent Development 7.4 Jhonson & Jhonson 7.4.1 Jhonson & Jhonson Company Information 7.4.2 Jhonson & Jhonson Introduction and Business Overview 7.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Jhonson & Jhonson Neurosurgery Drug Product Offerings 7.4.5 Jhonson & Jhonson Recent Development 7.5 ABBVIE 7.5.1 ABBVIE Company Information 7.5.2 ABBVIE Introduction and Business Overview 7.5.3 ABBVIE Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 ABBVIE Neurosurgery Drug Product Offerings 7.5.5 ABBVIE Recent Development 7.6 Takeda Pharmaceuticals 7.6.1 Takeda Pharmaceuticals Company Information 7.6.2 Takeda Pharmaceuticals Introduction and Business Overview 7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Offerings 7.6.5 Takeda Pharmaceuticals Recent Development 7.7 UCB 7.7.1 UCB Company Information 7.7.2 UCB Introduction and Business Overview 7.7.3 UCB Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 UCB Neurosurgery Drug Product Offerings 7.7.5 UCB Recent Development 7.8 IPSEN 7.8.1 IPSEN Company Information 7.8.2 IPSEN Introduction and Business Overview 7.8.3 IPSEN Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 IPSEN Neurosurgery Drug Product Offerings 7.8.5 IPSEN Recent Development 7.9 Standigm 7.9.1 Standigm Company Information 7.9.2 Standigm Introduction and Business Overview 7.9.3 Standigm Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Standigm Neurosurgery Drug Product Offerings 7.9.5 Standigm Recent Development 7.10 BlueStar Genomic 7.10.1 BlueStar Genomic Company Information 7.10.2 BlueStar Genomic Introduction and Business Overview 7.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 BlueStar Genomic Neurosurgery Drug Product Offerings 7.10.5 BlueStar Genomic Recent Development 7.11 Tonix Pharmaceuticals 7.11.1 Tonix Pharmaceuticals Company Information 7.11.2 Tonix Pharmaceuticals Introduction and Business Overview 7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Offerings 7.11.5 Tonix Pharmaceuticals Recent Development 7.12 BlackThorn Therapeutics 7.12.1 BlackThorn Therapeutics Company Information 7.12.2 BlackThorn Therapeutics Introduction and Business Overview 7.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Offerings 7.12.5 BlackThorn Therapeutics Recent Development 7.13 Quentrix 7.13.1 Quentrix Company Information 7.13.2 Quentrix Introduction and Business Overview 7.13.3 Quentrix Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Quentrix Neurosurgery Drug Product Offerings 7.13.5 Quentrix Recent Development 7.14 Wren Pharmaceuticals 7.14.1 Wren Pharmaceuticals Company Information 7.14.2 Wren Pharmaceuticals Introduction and Business Overview 7.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Offerings 7.14.5 Wren Pharmaceuticals Recent Development 8 Industry Chain Analysis 8.1 Neurosurgery Drug Industrial Chain 8.2 Neurosurgery Drug Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Neurosurgery Drug Sales Model 8.5.2 Sales Channel 8.5.3 Neurosurgery Drug Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
